Icad Inc (NASDAQ: ICAD) on Tuesday, soared 9.49% from the previous trading day, before settling in for the closing price of $1.58. Within the past 52 weeks, ICAD’s price has moved between $1.18 and $2.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -4.67% annually for the last half of the decade. The company achieved an average annual earnings per share of 15.74%. With a float of $25.05 million, this company’s outstanding shares have now reached $26.35 million.
In an organization with 69 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 85.32%, operating margin of -32.31%, and the pretax margin is -27.87%.
Icad Inc (ICAD) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Icad Inc is 5.63%, while institutional ownership is 23.28%.
Icad Inc (ICAD) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.02 earnings per share (EPS) for the period topping the consensus outlook (set at -0.05) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.00% during the next five years compared to 11.68% growth over the previous five years of trading.
Icad Inc (NASDAQ: ICAD) Trading Performance Indicators
Icad Inc (ICAD) is currently performing well based on its current performance indicators. A quick ratio of 3.91 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Icad Inc (ICAD)
Let’s dig in a bit further. During the last 5-days, its volume was 0.57 million. That was better than the volume of 0.18 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 23.38%. Additionally, its Average True Range was 0.17.
During the past 100 days, Icad Inc’s (ICAD) raw stochastic average was set at 43.90%, which indicates a significant increase from 28.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 151.40% in the past 14 days, which was higher than the 85.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7206, while its 200-day Moving Average is $1.5644. However, in the short run, Icad Inc’s stock first resistance to watch stands at $1.9067. Second resistance stands at $2.0833. The third major resistance level sits at $2.2867. If the price goes on to break the first support level at $1.5267, it is likely to go to the next support level at $1.3233. Assuming the price breaks the second support level, the third support level stands at $1.1467.
Icad Inc (NASDAQ: ICAD) Key Stats
Market capitalization of the company is 45.91 million based on 26,540K outstanding shares. Right now, sales total 17,320 K and income totals -4,850 K. The company made 4,220 K in profit during its latest quarter, and -1,800 K in sales during its previous quarter.
